FinDogFinDog
Wednesday, September 16, 2026Closing data · 4:00 PM ET
English
Log in

UNH

UnitedHealth GroupNYSE · Managed Health Care · Health Care
Previous close
375.26
Change
−0.67 / −0.18%
FinDog View
Neutral
52-Week Range
255.97 – 461.62
P/E (TTM)
23.9
Forward P/E
19.7
Based on consensus earnings for the next 12 months
Market Cap
$337B
1M
−5.15%
S&P 500 −2.41% over same period
Volume / Avg Volume
4.4M / 5.4M
0.81× average

Price History

Closing price · USD1M6M1Y5Y
250300350400450FY26 Q2 EarningsFY26 Q1 Earnings2026-032026-052026-062026-082026-09

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 23.61M6M1Y5Y
10203040502023-082024-052025-032025-122026-09

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis
FY2026 Q2
Quarter ended 2026-06
2026-07-16$112B6.38 / 4.95+0.64%Pending
FY2026 Q1
Quarter ended 2026-03
2026-04-21$112B7.23 / 6.64+2.17%Pending
FY2025 Q4
Quarter ended 2025-12
2026-01-27—— / —+4.00%Pending
FY2025 Q3
Quarter ended 2025-09
2025-10-28—— / —−3.42%Pending
FY2025 Q2
Quarter ended 2025-06
2025-07-29—— / —+1.90%Pending
FY2025 Q1
Quarter ended 2025-03
2025-04-17—— / —−6.34%Pending

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 53 of its 5-year rangeMid-range
5-year range 12.6 – 38.7 · Median 23.6
Last 4 quarters: $1.6B in buybacks + $8.1B in dividends, 2.89% of market cap combined
P/E (TTM)
23.9
P/B
3.2
P/S
0.8
Dividend Yield
1.37%
Earnings Reaction
Over the last 6 reports, the stock moved ±3.1% on average on the first trading day after, rising 4 times
Most recent +0.64%
Volatility & Correlation
1-year beta 0.41 · Correlation with S&P 500 0.15Low beta
Annualized volatility 35% vs. 13% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 2 · $0.66MNet selling $0.66M
  • 08-21Conway Patrick HughChief Executive Officer, OptumSell$0.46M1,169 shares · Avg price 390.00
  • 08-05Conway Patrick HughChief Executive Officer, OptumSell$0.21M500 shares · Avg price 410.00
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q2112.03+0.4%88.1%7.995.4810.256.04
FY2026 Q1111.72+2.0%88.5%8.996.288.156.90
FY2025 Q4113.22+12.3%88.8%0.380.010.160.05
FY2025 Q3113.16+12.2%88.9%4.322.355.062.59
FY2025 Q2111.62+12.9%88.3%5.153.416.303.74
FY2025 Q1109.58+9.8%88.7%9.126.294.566.85
FY2024 Q4100.81+6.8%87.6%7.775.541.465.99
FY2024 Q3100.82+9.2%88.3%8.716.0612.956.51
FY2024 Q298.86+6.4%88.5%7.884.225.894.54
FY2024 Q199.80+8.6%88.9%7.93-1.410.40-1.53
FY2023 Q494.43+14.1%89.2%7.695.46-6.155.85
FY2023 Q392.36+14.2%89.8%8.535.846.066.24

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView
UNHUnitedHealth Group$337B23.9+0.4%88.1%−5.15%Neutral
LLYLilly (Eli)$1.07T39.9+47.7%85.8%−3.83%BullishCompare
JNJJohnson & Johnson$644B30.6+6.6%68.2%+1.87%BullishCompare
ABBVAbbVie$464B73.7+10.2%74.7%+4.87%NeutralCompare
MRKMerck & Co.$358B112.2+5.1%73.5%+6.57%NeutralCompare
TMOThermo Fisher Scientific$240B34.4+10.5%—+10.75%BullishCompare
AMGNAmgen$203B23.3+9.5%72.0%−10.26%NeutralCompare
GILDGilead Sciences$183B—+10.2%79.8%+6.31%NeutralCompare
ABTAbbott Laboratories$177B33.2+7.8%56.2%−7.26%NeutralCompare